Skip to main content
Fig. 5 | Arthritis Research & Therapy

Fig. 5

From: Soluble syndecan-3 binds chemokines, reduces leukocyte migration in vitro and ameliorates disease severity in models of rheumatoid arthritis

Fig. 5

Soluble syndecan-3 occurs in the sera of patients with inflammatory autoimmune diseases. a Levels of syndecan-3 in the sera of patients with rheumatoid arthritis (RA; n = 47) and periodontitis (Perio; n = 13). Data show medians and 95% confidence intervals. ***P < 0.001 (Mann Whitney U test). b Correlation in the serum levels between syndecan-3 and syndecan-1 in RA sera (correlation coefficient r = 0.76; P < 0.0001)

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us